EP. 1: CLEAR Outocmes Trial Overview: Non-Statin Therapies for Patients with Atherosclerotic Cardiovascular Disease (ASCVD)
Leslie Cho, MD, FACC, FESC, FSCAI, and Seth S. Martin, MD, MHS, FACC, FAHA, FASPC, open a discussion regarding therapies for statin-intolerant patients with ASCVD and provide an overview of the CLEAR Outcomes clinical trial.
Watch
EP. 2: Mechanism of Action: Bempedoic Acid vs Statins
Bempedoic acid provides an effective treatment alternative for patients with statin intolerance due to differences in mechanisms of action.
EP. 3: Examining CLEAR Outcomes Trial Structure
Key opinion leaders discuss parameters and limitations of the CLEAR Outcomes clinical trial.
EP. 4: Key Data Analysis from CLEAR Outcomes Trial
Medical experts highlight key findings from the CLEAR Outcomes trial.
EP. 5: Adverse Event Profile of Bempedoic Acid
Drs Cho and Martin examine the side effect profile associated with bempedoic acid.
EP. 6: Advantages of Bempedoic Acid in Cardiovascular Disease Treatment Landscape
In their final thoughts, the experts illustrate the overall effect of bempedoic acid for statin-intolerant patients with atherosclerotic cardiovascular disease.
